These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3958370)

  • 21. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction.
    Campbell RW; Dolder MA; Prescott LF; Talbot RG; Murray A; Julian DG
    Lancet; 1975 Jun; 1(7919):1257-60. PubMed ID: 48894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Newer antiarrhythmic drugs in children.
    Moak JP; Smith RT; Garson A
    Am Heart J; 1987 Jan; 113(1):179-85. PubMed ID: 3099560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral mexiletine in the treatment of refractory ventricular arrhythmias: the role of electrophysiologic techniques.
    Schoenfeld MH; Whitford E; McGovern B; Garan H; Ruskin JN
    Am Heart J; 1984 May; 107(5 Pt 2):1071-8. PubMed ID: 6372423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of mexiletine, ajmaline and aprindine on ventricular arrhythmias].
    Pozenel H
    Adv Clin Pharmacol; 1978; 16():125-37. PubMed ID: 356551
    [No Abstract]   [Full Text] [Related]  

  • 26. Long term efficacy of class I antiarrhythmic agents and amiodarone in patients with malignant ventricular arrhythmias.
    Schmidt G; Goedel-Meinen L; Jahns G; Linné R; Schaudig U; Kein G; Baedeker W; Wirtzfeld A
    Drugs; 1985 Mar; 29 Suppl 3():37-46. PubMed ID: 3996244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mexiletine in the treatment of ventricular arrhythmias.
    Henrard L; Carlier J
    Acta Cardiol Suppl; 1980; (25):127-35. PubMed ID: 6966452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International mexiletine and placebo antiarrhythmic coronary trial: I. Report on arrhythmia and other findings. Impact Research Group.
    J Am Coll Cardiol; 1984 Dec; 4(6):1148-63. PubMed ID: 6209318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Medical management of tachycardias (author's transl)].
    Petri H; Rudolph W
    Herz; 1979 Aug; 4(4):344-58. PubMed ID: 93075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of ventricular extrasystole with mexiletine and Neo-gilurytmal in myocardial infarct patients].
    Loskot F; Bauer U
    Adv Clin Pharmacol; 1978; 16():75-80. PubMed ID: 80103
    [No Abstract]   [Full Text] [Related]  

  • 31. Mexiletine: an effective antiarrhythmic drug for treatment of ventricular arrhythmias in congenital heart disease.
    Moak JP; Smith RT; Garson A
    J Am Coll Cardiol; 1987 Oct; 10(4):824-9. PubMed ID: 3655149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative multicenter clinical study of flecainide and amiodarone in the treatment of ventricular arrhythmias associated with chronic Chagas cardiopathy].
    Rosenbaum M; Posse R; Sgammini H; Núñez Burgos J; Chiale PA; Pastori JD; González Zuelgaray J; Brunetto JF; Califano JE
    Arch Inst Cardiol Mex; 1987; 57(4):325-30. PubMed ID: 2445316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic drug therapy. Recent advances and current status.
    Somberg J
    Cardiology; 1985; 72(5-6):329-48. PubMed ID: 2866841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mexiletine in the treatment of ventricular arrhythmias (author's transl)].
    Schlemmer M; Wimmer M
    Padiatr Padol; 1982; 17(2):383-9. PubMed ID: 6179031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone.
    Vazquez Blanco M; Milei J; Piñeiro DJ; Buceta JE; Dreyer MP
    Acta Cardiol; 1983; 38(2):125-32. PubMed ID: 6603085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias.
    Kim SG; Mercando AD; Tam S; Fisher JD
    J Am Coll Cardiol; 1989 Mar; 13(3):659-64. PubMed ID: 2918173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New drugs for treating cardiac arrhythmias.
    Benchimol A; Desser KB
    Postgrad Med; 1981 Jan; 69(1):77-84. PubMed ID: 6780988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mexiletine in refractory ventricular arrhythmias.
    Fenster PE; Kern KB
    Clin Pharmacol Ther; 1983 Dec; 34(6):777-84. PubMed ID: 6641093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic efficacy of combined intravenous and oral mexiletine in acute myocardial infarction. A double blind placebo-controlled study.
    Halinen MO; Pentikäinen PJ; Helin MJ; Rehnberg S
    Eur Heart J; 1984 Aug; 5(8):675-83. PubMed ID: 6383836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.